Participated · Equity · Oct 2025

Andel is building a cooperative pharmacy-benefit platform that pools the buying power of employer members to buy GLP-1 weight-loss medications and other costly branded drugs directly from manufacturers at below-market rates. Employers choose a subsidy level, and Andel handles prescription verification, payment, and next-day delivery through its native applications and wholly owned Andel Pharmacy, LLC. By bypassing traditional pharmacy-benefit managers, the model aims to lower costs for employers while giving employees immediate access to brand-name medicines without prior-authorization hurdles. Co-founders Jay Bregman—whose prior ventures include Hailo and Thimble—and pharmacist Ritu Malhotra, PharmD, combine startup and healthcare-benefits expertise to navigate the complex drug-pricing ecosystem. The company announced plans to launch nationwide in early 2026. Andel has raised $4.5 million to fund this rollout, but it has not yet disclosed revenue, user, or prescription-volume metrics.

Participated · Seed · Oct 2025

Gladys offers an AI-supported marketplace that directly connects people seeking home care with vetted local carers, eliminating traditional agency intermediaries. Its technology automates matching, scheduling, and back-office logistics, which reduces client costs and enables carers to earn up to 65% more than standard agency rates. Since launch, the platform has delivered care across a 20,000 km catchment area and facilitated tens of thousands of hours of independent living support. Co-founded by Georgina Robinson and Alex Sorisi, the company emphasizes fair pay, career development tools for carers, and high-quality support for clients. With fresh seed funding, Gladys plans a nationwide rollout, deployment of additional AI back-office agents, and investment in local care communities. The team aims to provide hundreds of thousands of hours of support by the end of 2026, positioning the business for rapid scale across the UK.

Participated · Series A · Apr 2025

Venteur provides a personalized health technology platform that helps employers offer employees tailored health benefits and full control over their choices via Individual Coverage Health Reimbursement Arrangements (ICHRA). The platform serves a range of companies, from small teams to businesses with over 5,000 employees. Venteur reports having served 30,000 employees across 600 businesses. The company is led by Stacy and Tim Edgar and is based in San Francisco, CA. Venteur plans to use its new funding to accelerate product innovation, expand into new markets, and grow its team. The product emphasis is on giving employees high-quality, personalized options rather than one-size-fits-all employer plans. Venteur operates a health insurance platform and services that enable businesses to provide their employees with more choice and control over care. The company positions its product to prioritize employee well-being and financial success. Venteur combines platform capabilities with services to simplify employer-sponsored health benefits. The startup is based in Berkeley, California. It recently completed a seed financing, indicating early-stage funding activity. Venteur plans to use the new capital to expand operations and advance its product development efforts.

Participated · Seed · Feb 2025

Firstwork builds an AI-powered workforce management platform designed to streamline and automate HR processes for frontline workers. The platform helps businesses onboard and manage frontline employees more efficiently and is already used by customers including Relay in London and Oway in California. Founded in 2024 by Vardhan Kapoor and Shubham Choudhary, the company is headquartered in San Francisco, CA. Firstwork closed a $5M Seed funding round to support its growth. The company intends to use the funds to expand operations and broaden its business reach. No revenue or user metrics were disclosed in the article.

Participated · Seed · Nov 2024

Heim Health operates an API-led software platform that sources highly skilled nurses and other practitioners to deliver care in patients' homes, supporting appointments such as blood tests, post-operative assessments and injections. Its proprietary assignment algorithms and technology aim to unlock latent workforce capacity, make home-based care cost-effective and reduce pressure on hospital staff. Patients access a simple interface to book, change or cancel at-home appointments, improving access for older people and those with mobility or additional needs. Heim partners with both private healthcare organisations and the NHS to manage end-to-end delivery and scale community-based care. The company cites that 13% of NHS beds are occupied by people who could receive care in the community, underpinning its mission to shift more care into the home. Heim was formerly known as Ally Health and was founded by the team behind the Testing For All not-for-profit Covid testing service.